Showing results (1621-1630 of 4,073) with videos related to
Sort By:
Pageof 408
Journal of Thrombosis and Thrombolysis|April 26, 2011
Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban--an oral, direct and selective factor Xa inhibitorRichard C Becker, Hongqiu Yang, Yuchen Barrett, et al.The Journal of Investigative Dermatology|March 29, 2002
Expression of stress-induced MHC class I related chain molecules on human melanomaClaudia S Vetter, Veronika Groh, Per thor Straten, et al.European Journal of Immunology|July 1, 1997
Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiencyS Cayeux, G Richter, C Becker, et al.Der Radiologe|February 5, 1999
[Significance of calcium detection with electron-beam tomography in coronary disease]R Haberl, A Knez, A Becker, et al.Frontiers in Neuroscience|March 12, 2014
Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent modelsRachel I Anderson, Howard C Becker, Benjamin L Adams, et al.BJC Reports|November 8, 2024
Comparative efficacy of combined CTLA-4 and PD-1 blockade vs. PD-1 monotherapy in metastatic melanoma: a real-world studyAvital Klein-Brill, Shlomit Amar-Farkash, Keren Rosenberg-Katz, et al.Zentralblatt Fur Chirurgie|June 9, 2001
[Experimental validation of DXA and MRI-based bone density measurement by ash-method]C Becker, A W Baltzer, M Schneppenheim, et al.Neuropharmacology|February 12, 2000
Delta-opioid receptor-mediated increase in cortical extracellular levels of cholecystokinin-like material by subchronic morphine in ratsC Becker, M Pohl, M H Thiébot, et al.The Journal of Investigative Dermatology|April 20, 2000
Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanomaC S Vetter, P T Straten, P Terheyden, et al.Journal of Cancer Research and Clinical Oncology|January 10, 2022
The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapyL Susok, S Said, D Reinert, et al.Pageof 408